Azithromycin Powder, For Suspension
NDC Package 70710-1457-1
Package Information
Azithromycin powders is azithromycin is indicated in adult patients for the treatment of mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:Acute bacterial exacerbations of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis,or Streptococcus pneumoniae.Acute bacterial sinusitis due to Haemophilus influenzae, Moraxella catarrhalis,or Streptococcus pneumoniae.Community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae,or Streptococcus pneumoniaein patients appropriate for oral therapy.Pharyngitis/tonsillitis caused by Streptococcus pyogenesas an alternative to first-line therapy in individuals who cannot use first-line therapy.Uncomplicated skin and skin structure infections due to Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiae.Urethritis and cervicitis due to Chlamydia trachomatisor Neisseria gonorrhoeae.Genital ulcer disease in men due to Haemophilus ducreyi(chancroid). This formulation utilizes a powder, for suspension delivery system. Marketed by Zydus Pharmaceuticals Usa Inc., this product is identified by NDC 70710-1457 and is authorized under FDA application ANDA211147.
Identification & Billing
- RxCUI: 141963 - azithromycin 200 MG in 5 mL Oral Suspension
- RxCUI: 141963 - azithromycin 40 MG/ML Oral Suspension
- RxCUI: 141963 - azithromycin 1200 MG per 30 ML Oral Suspension
- RxCUI: 141963 - azithromycin 200 MG per 5 ML Oral Suspension
- RxCUI: 141963 - azithromycin 600 MG per 15 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70710 - Zydus Pharmaceuticals Usa Inc.
- 70710-1457 - Azithromycin
- 70710-1457-1 - 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
- 70710-1457 - Azithromycin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70710-1457-1 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Azithromycin, a human prescription drug labeled by Zydus Pharmaceuticals Usa Inc.. This powder, for suspension is formulated for oral use and contains azithromycin dihydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zydus Pharmaceuticals Usa Inc. on August 06, 2018. The current certification is valid through December 31, 2027.
How is this Zydus Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70710145701. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.